First results for resetting the antitumor immune response by immune corrective surgery in colon cancer

American Journal of Surgery

Volumn 176, Issue 4, 1998, Pages 339-343

  Barbera Guillem, Emilio ^a,b   Arnold, Mark W ^c   Nelson, M Bud ^b,d   Martin Jr, Edward W ^c,d  

^a UNIVERSITY OF VALENCIA   (Spain)

^b Phylatron (EB G   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ANTIBODY; IODINE 125; MONOCLONAL ANTIBODY; TUMOR ANTIGEN;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTATION; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CELLULAR IMMUNITY; CLINICAL ARTICLE; COLON CANCER; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMORAL IMMUNITY; ISOTOPE LABELING; LYMPHADENECTOMY; PRIORITY JOURNAL; SURVIVAL RATE;

EID: 0031730068     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(98)00192-5     Document Type: Article

References (35)

1. Cohen AM, Minsky BO, Schilsky RL. Colon cancer. In: DeVita V Jr, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 4th ed. Philadelphia: JB Lippencott, 1993:929-927.
2. Weiss L. Principles of Metastasis. 1985;Academic Press, Orlando.
3. Somers S.S. Surgical implications of tumour immunology. Ann R Coll Surg Engl. 78:1996;103-109.
4. Pekarek L.A., Starr B.A., Toledano A.Y., Schreiber H. Inhibition of tumor growth by elimination of granulocytes. J Exp Med. 181:1995;435-440.
5. Roselli M., Hitchcock C.L., Molinolo A., et al. Autoradiographic evaluation of radiolabeled monoclonal antibody B72.3 distribution in tumor and lymph nodes of adenocarcinoma patients. Anticancer Res. 15:1995;975-984.
6. Arnold M.W., Young D.C., Hitchcock C.L., et al. Radioimmunoguided surgery in primary colorectal carcinoma an intraoperative prognostic tool and adjuvant to traditional staging . Am J Surg. 170:1995;315-318.
7. Seung L.P., Seung S.K., Schreiber H. Antigenic cancer cells that escape immune destruction are stimulated by host cells. Cancer Res. 55:1995;5094-5100.
8. Denis M.G., Lipart C., Leborgne J., et al. Detection of disseminated tumor cells in peripheral blood of colorectal cancer patients. Int J Cancer. 74:1997;540-544.
9. Kawakami M., Okaneya T., Furihata K., et al. Detection of prostate cancer cells circulating in peripheral blood by reverse transcription-PCR for hKLK2. Cancer Res. 57:1997;4167-4170.
10. Dingemans A.M., Brakenhoff R.H., Postmus P.E., Giaccone G. Detection of cytokeratin-19 transcripts by reverse transcriptase-polymerase chain reaction in lung cancer cell lines and blood of lung cancer patients. Lab Invest. 77:1997;213-220.
11. Glaser R., Rass K., Seiter S., et al. Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients a clinical two-center study . J Clin Oncol. 15:1997;2818-2825.
12. Soeth E., Vogel I., Juhl H., et al. Comparative study of the dissemination of tumor cells in bone marrow and peripheral blood in stomach and colorectal carcinoma with RT-PCR. Langenbecks Arch Chir Suppl Kongressbd. 114:1997;793-796.
13. Funaki N.O., Tanaka J., Itami A., et al. Detection of colorectal carcinoma cells in circulating peripheral blood by reverse transcription-polymerase chain reaction targeting cytokeratin-20 mRNA. Life Sci. 60:1997;643-652.
14. Soeth E., Vogel I., Roder C., et al. Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res. 57:1997;3106-3110.
15. Pricolo V.E., Finkelstein S.D., Wu T.T., et al. Prognostic value of TP53 and K-ras-2 mutational analysis in stage III carcinoma of the colon. Am J Surg. 171:1996;41-46.
16. Mulder J.W., Baas I.O., Polak M.M., et al. Evaluation of p53 protein expression as a marker for long-term prognosis in colorectal carcinoma. Br J Cancer. 71:1995;1257-1262.
17. DiGiorgio A., Botti C., Mingazzini P., et al. Gastric cancer prognosis and lymph node reactivity . Eur J Surg. 161:1995;575-580.
18. Krajewski S., Bodrug S., Gascoyne R., et al. Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes. Am J Pathol. 145:1994;515-525.
19. Ohsawa M., Kanno H., Machii T., Aozasa K. Immunoreactivity of neoplastic and non-neoplastic monocytoid B lymphocytes for DBA.44 and other antibodies. J Clin Pathol. 47:1994;928-932.
20. Check I.J., Cobb M., Hunter R.L. The relationship between cytotoxicity and prognostically significant histologic changes in lymph nodes from patients with cancer of the breast. Am J Pathol. 98:1980;325-338.
21. DeClerck Y.A., Imren S., Montgomery A.M., et al. Proteases and protease inhibitors in tumor progression. Adv Exp Med Biol. 425:1997;89-97.
22. Ruf W., Mueller B.M. Tissue factor in cancer angiogenesis and metastasis. Curr Opin Hematol. 3:1996;379-384.
23. Theodoropoulos G.E., Panoussopoulos D., Lazaris A.C., Golematis B.C. Evaluation of cathepsin D immunostaining in colorectal adenocarcinoma. J Surg Oncol. 65:1997;242-248.
24. Price J.T., Bonovich M.T., Kohn E.C. The biochemistry of cancer dissemination. Crit Rev Biochem Mol Biol. 32:1997;175-253.
25. Czubayko F., Liaudet-Coopman E.D., Aigner A., et al. A secreted FGF-binding protein can serve as the angiogenic switch in human cancer. Nat Med. 3:1997;1137-1140.
26. Fukumura D., Yuan F., Monsky W.L., et al. Effect of host microenvironment on the microcirculation of human colon adenocarcinoma. Am J Pathol. 151:1997;679-688.
27. Takahashi Y., Bucana C.D., Liu W., et al. Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis role of infiltrating cells . J Natl Cancer Inst. 88:1996;1146-1151.
28. Monach P.A., Schreiber H., Rowley D.A. D4+ and B lymphocytes in transplantation immunity. II. Augmented rejection of tumor allografts by mice lacking B cells. Transplantation. 5:1993;1356-1361.
29. Kosco-Vilbois M.H., Gray D., Scheidegger D., Julius M. Follicular dendritic cells help resting B cells to become effective antigen-presenting cells induction of B7/BB1 and upregulation of major histocompatibility complex class II molecules . J Exp Med. 178:1993;2055-2066.
30. Cote R.J., Houchens D.P., Hitchcock C.L., et al. Intraoperative detection of occult colon cancer micrometastases using 125 I-radiolabled monoclonal antibody CC49. Cancer. 77:1996;613-620.
31. Martinez D., Barbera-Guillem E., LaValle G., Martin E.W. Jr. Radioimmunoguided surgery for gastrointestinal malignancies an analysis of 14 years of clinical experience . Cancer Control. 4:1997;505-516.
32. Arnold M.W., Hitchcock C.L., Young D.C., et al. Intra-abdominal patterns of disease dissemination in colorectal cancer identified using radioimmunoguided surgery. Dis Colon Rectum. 39:1996;509-513.
33. Bansal S.C., Bansal B.R., Thomas H.L., et al. Ex vivo removal of serum IgG in a patient with colon carcinoma. Cancer. 42:1978;1-18.
34. Manz R.A., Thiel A., Radbruch A. Lifetime of plasma cells in the bone marrow. Nature. 388:1997;133-134.
35. Seung L.P., Rowley D.A., Dubey P., Schreiber H. Synergy between T-cell immunity and inhibition of paracrine stimulation causes tumor rejection. Proc Natl Acad Sci USA. 92:1995;6254-6258.